These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 20411786)

  • 41. Effect of siRNA-induced silencing of cellular prion protein on tyrosine hydroxylase expression in the substantia nigra of a rat model of Parkinson's disease.
    Wang X; Yang HA; Wang XN; Du YF
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27173342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative review of adult midbrain and striatum neurogenesis with classical neurogenesis.
    Farzanehfar P
    Neurosci Res; 2018 Sep; 134():1-9. PubMed ID: 29339103
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibiting BDNF expression by antisense oligonucleotide infusion causes loss of nigral dopaminergic neurons.
    Porritt MJ; Batchelor PE; Howells DW
    Exp Neurol; 2005 Mar; 192(1):226-34. PubMed ID: 15698637
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resident adult neural stem cells in Parkinson's disease--the brain's own repair system?
    van den Berge SA; van Strien ME; Hol EM
    Eur J Pharmacol; 2013 Nov; 719(1-3):117-127. PubMed ID: 23872414
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human adipose-derived mesenchymal stromal cells increase endogenous neurogenesis in the rat subventricular zone acutely after 6-hydroxydopamine lesioning.
    Schwerk A; Altschüler J; Roch M; Gossen M; Winter C; Berg J; Kurtz A; Steiner B
    Cytotherapy; 2015 Feb; 17(2):199-214. PubMed ID: 25457280
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Cortical Pathogenic Theory of Parkinson's Disease.
    Foffani G; Obeso JA
    Neuron; 2018 Sep; 99(6):1116-1128. PubMed ID: 30236282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
    Mogi M; Kondo T; Mizuno Y; Nagatsu T
    Neurosci Lett; 2007 Feb; 414(1):94-7. PubMed ID: 17196747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
    Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
    Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
    [TBL] [Abstract][Full Text] [Related]  

  • 49. New striatal neurons form projections to substantia nigra in adult rat brain after stroke.
    Sun X; Zhang QW; Xu M; Guo JJ; Shen SW; Wang YQ; Sun FY
    Neurobiol Dis; 2012 Jan; 45(1):601-9. PubMed ID: 22005319
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Differential alterations in nicotinic receptor alpha6 and beta3 subunit messenger RNAs in monkey substantia nigra after nigrostriatal degeneration.
    Quik M; Polonskaya Y; Gillespie A; K Lloyd G; Langston JW
    Neuroscience; 2000; 100(1):63-72. PubMed ID: 10996459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A possible role for dopamine D3 receptor stimulation in the induction of neurogenesis in the adult rat substantia nigra.
    Van Kampen JM; Robertson HA
    Neuroscience; 2005; 136(2):381-6. PubMed ID: 16216425
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease.
    Sulzer D
    Trends Neurosci; 2007 May; 30(5):244-50. PubMed ID: 17418429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
    Yoon MC; Shin MS; Kim TS; Kim BK; Ko IG; Sung YH; Kim SE; Lee HH; Kim YP; Kim CJ
    Neurosci Lett; 2007 Aug; 423(1):12-7. PubMed ID: 17644250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Partial loss of dopaminergic neurons in the substantia nigra, ventrotegmental area and the retrorubral area -- model of the early beginning of Parkinson's symptomatology?
    Heim C; Sova L; Kurz T; Kolasiewicz W; Schwegler H; Sontag KH
    J Neural Transm (Vienna); 2002 May; 109(5-6):691-709. PubMed ID: 12111461
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Converging roles of ion channels, calcium, metabolic stress, and activity pattern of Substantia nigra dopaminergic neurons in health and Parkinson's disease.
    Duda J; Pötschke C; Liss B
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):156-178. PubMed ID: 26865375
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cell transplantation in the damaged adult brain.
    Jaber M; Benoit-Marand M; Prestoz L; Gaillard A
    Rev Neurol (Paris); 2013 Nov; 169(11):838-43. PubMed ID: 24112517
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced BDNF mRNA expression in the Parkinson's disease substantia nigra.
    Howells DW; Porritt MJ; Wong JY; Batchelor PE; Kalnins R; Hughes AJ; Donnan GA
    Exp Neurol; 2000 Nov; 166(1):127-35. PubMed ID: 11031089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Iron as a vulnerability factor in nigrostriatal degeneration in aging and Parkinson's disease.
    Floor E
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):709-20. PubMed ID: 10875434
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neuronal hypertrophy in the pars reticulata of the substantia nigra in Parkinson's disease.
    Neal JW; Pearson RC; Cole G; Powell TP
    Neuropathol Appl Neurobiol; 1991 Jun; 17(3):203-6. PubMed ID: 1891064
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early Postnatal but Not Late Adult Neurogenesis Is Impaired in the Pitx3-Mutant Animal Model of Parkinson's Disease.
    Brandt MD; Krüger-Gerlach D; Hermann A; Meyer AK; Kim KS; Storch A
    Front Neurosci; 2017; 11():471. PubMed ID: 28883785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.